Cargando…

Patients’ perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain

PURPOSE: Ulcerative colitis (UC) may cause many patients to miss out on important personal and professional opportunities. We therefore conducted a survey (UC-LIFE) to assess patients’ perceptions of the impact of UC on social and professional lives. PATIENTS AND METHODS: Consecutive unselected UC p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvet, Xavier, Argüelles-Arias, Federico, López-Sanromán, Antonio, Cea-Calvo, Luis, Juliá, Berta, de Santos, Cristina Romero, Carpio, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154710/ https://www.ncbi.nlm.nih.gov/pubmed/30271125 http://dx.doi.org/10.2147/PPA.S175026

Ejemplares similares

Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis
por: Yan, Brian M., et al.
Publicado: (2021)

Construction of an Explanatory Model for Quality of Life in Outpatients with Ulcerative Colitis
por: Takahashi, Miho, et al.
Publicado: (2023)

Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
por: Jentzer, Alexandre, et al.
Publicado: (2020)

Anti-ulcerogenic and anti-ulcerative colitis (UC) activities of seven amines derivatives
por: Awaad, Amani S., et al.
Publicado: (2017)

Prevalence of Intestinal Protozoan Infection in Patients with Ulcerative Colitis (UC) in Isfahan, Iran
por: Pestechian, Nader, et al.
Publicado: (2021)

Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC)
por: Nasir, Syed Alishan, et al.
Publicado: (2022)

Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn’s Disease (CD) and Ulcerative Colitis (UC)
por: Kikut, Justyna, et al.
Publicado: (2022)

Potential Biomarkers Associated with Differential Manifestations of Ulcerative Colitis (UC) in Uyghur and Han Population in China
por: Lu, Jia Jie, et al.
Publicado: (2021)

Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diary
por: Higgins, Peter D. R., et al.
Publicado: (2018)

Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study
por: Maaser, Christian, et al.
Publicado: (2020)

Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound Index
por: Bots, Steven, et al.
Publicado: (2021)

Using a Deep Learning Model to Address Interobserver Variability in the Evaluation of Ulcerative Colitis (UC) Severity
por: Kim, Jeong-Heon, et al.
Publicado: (2023)

Dose Escalation of Biologics in Biologic-Naïve Patients With Ulcerative Colitis: Outcomes From the ODESSA-UC Study
por: Ghosh, Sabyasachi, et al.
Publicado: (2023)

Evaluation of diet pattern related to the symptoms of mexican patients with Ulcerative Colitis (UC): through the validity of a questionnaire
por: Bueno-Hernández, Nallely, et al.
Publicado: (2015)

Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC)
por: Li, Wendy, et al.
Publicado: (2021)

Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
por: Irani, Malcolm, et al.
Publicado: (2023)

Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients
por: Iborra, Marisa, et al.
Publicado: (2020)

Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity
por: Belvis Jiménez, María, et al.
Publicado: (2021)

Quality of life in patients with ulcerative colitis treated surgically
por: Kozłowska, Katarzyna A., et al.
Publicado: (2014)

Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis
por: Klepp, Pasquale, et al.
Publicado: (2018)

DNA Methylation Status of Epithelial-Mesenchymal Transition (EMT) - Related Genes Is Associated with Severe Clinical Phenotypes in Ulcerative Colitis (UC)
por: Tahara, Tomomitsu, et al.
Publicado: (2014)

Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial
por: Sarbagili Shabat, Chen, et al.
Publicado: (2021)

Real-life evaluation of histologic scores for Ulcerative Colitis in remission
por: Arkteg, Christian Børde, et al.
Publicado: (2021)

Ulcerative Colitis and Patient’s Quality of Life, Especially in Early Stage
por: Lee, Jung Won
Publicado: (2022)

A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study
por: Sarbagili-Shabat, Chen, et al.
Publicado: (2021)

Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland
por: Kawalec, Paweł, et al.
Publicado: (2017)

Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers
por: Tursi, Antonio, et al.
Publicado: (2018)

Fecal S100A12 levels measured by a new ELISA are increased in ulcerative colitis (UC) and Crohn’s disease (CD) and correlates with intestinal damage
por: Garnero, P, et al.
Publicado: (2010)

Validation of a self-reported work disability questionnaire for ulcerative colitis
por: Ramos, Alexis, et al.
Publicado: (2018)

Health-related quality of life in patients with long-standing ulcerative colitis in remission
por: Mavroudis, Georgios, et al.
Publicado: (2022)

Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis
por: Dubinsky, Marla C, et al.
Publicado: (2022)

Differences in the Quality of Life of Patients Recently Diagnosed with Crohn’s Disease and Ulcerative Colitis
por: Bernabéu Juan, Purificación, et al.
Publicado: (2023)

Golimumab for the treatment of ulcerative colitis
por: Flamant, Mathurin, et al.
Publicado: (2017)

Inflammatory Potential of the Diet and Incidence of Crohn’s Disease and Ulcerative Colitis in the EPIC-Spain Cohort
por: Guevara, Marcela, et al.
Publicado: (2021)

Professional quality of life, self‐compassion, resilience, and empathy in healthcare professionals during COVID‐19 crisis in Spain
por: Ruiz‐Fernández, María D., et al.
Publicado: (2021)

Professional Quality of Life and Perceived Stress in Health Professionals before COVID-19 in Spain: Primary and Hospital Care
por: Ortega-Galán, Ángela María, et al.
Publicado: (2020)

Health-Related Quality of Life in Chinese Patients with Mild and Moderately Active Ulcerative Colitis
por: Zheng, Kai, et al.
Publicado: (2015)

Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis
por: Beilman, Candace L., et al.
Publicado: (2016)

Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland
por: Perrig, Kathrin, et al.
Publicado: (2022)

REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis: A Canadian IBD Research Consortium Multicenter National Cohort Study
por: Ma, Christopher, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h914batpfg17skt1n80sgdlq9p